Derek J Maetzold Castle Biosciences Inc (CSTL) insider trading activity

Derek J Maetzold is Pres. & Chief Exec. Officer of CASTLE BIOSCIENCES INC. Currently has a direct ownership of 29,513 shares of CSTL, which is worth approximately $987,209. The most recent transaction as insider was on Jan 06, 2026, when has been sold 1,339 shares (Common Stock) at a price of $40.1 per share, resulting in proceeds of $53,693. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.5K

54.12% 3M change

63.92% 12M change

Total Value Held $987,209

DEREK J MAETZOLD Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 06 2026	SELL Open market or private sale	$53,693 $40.1 p/Share	1,339 Reduced 4.34%	29,513 Common Stock
Jan 05 2026	SELL Open market or private sale	$102,005 $38.09 p/Share	2,678 Reduced 7.99%	30,852 Common Stock
Dec 22 2025	SELL Open market or private sale	$33,490 $40.35 p/Share	830 Reduced 2.42%	33,530 Common Stock
Dec 17 2025	SELL Open market or private sale	$20,380 $40.04 p/Share	509 Reduced 1.46%	34,360 Common Stock
Dec 16 2025	SELL Open market or private sale	$494,249 $38.55 p/Share	12,821 Reduced 26.88%	34,869 Common Stock
Dec 15 2025	SELL Open market or private sale	$762,060 $39.03 p/Share	19,525 Reduced 29.05%	47,690 Common Stock
Dec 10 2025	SELL Payment of exercise price or tax liability	$230,781 $38.02 p/Share	6,070 Reduced 8.28%	67,215 Common Stock

Dec 10 2025	BUY Exercise of conversion of derivative security	-	15,424 Added 17.39%	73,285 Common Stock
Dec 09 2025	SELL Payment of exercise price or tax liability	$504,173 $38.25 p/Share	13,181 Reduced 18.55%	57,861 Common Stock
Dec 09 2025	BUY Exercise of conversion of derivative security	-	33,495 Added 32.04%	71,042 Common Stock
Dec 04 2025	SELL Open market or private sale	$53,600 $40.03 p/Share	1,339 Reduced 3.44%	37,547 Common Stock
Dec 02 2025	SELL Open market or private sale	$105,057 $39.23 p/Share	2,678 Reduced 6.44%	38,886 Common Stock
Nov 26 2025	SELL Open market or private sale	$170,703 $40.09 p/Share	4,258 Reduced 9.29%	41,564 Common Stock
Nov 25 2025	SELL Open market or private sale	$204,855 $40.05 p/Share	5,115 Reduced 10.04%	45,822 Common Stock
Nov 18 2025	SELL Open market or private sale	$91,105 $34.02 p/Share	2,678 Reduced 4.99%	50,937 Common Stock
Nov 05 2025	SELL Open market or private sale	$85,294 $31.85 p/Share	2,678 Reduced 4.76%	53,615 Common Stock
Nov 04 2025	SELL Open market or private sale	$206,005 $30.77 p/Share	6,695 Reduced 10.63%	56,293 Common Stock
Oct 20 2025	SELL Open market or private sale	$30,047 $22.44 p/Share	1,339 Reduced 2.08%	62,988 Common Stock
Oct 02 2025	SELL Open market or private sale	$30,234 $22.58 p/Share	1,339 Reduced 2.04%	64,327 Common Stock
Sep 17 2025	SELL Open market or private sale	$29,417 $21.97 p/Share	1,339 Reduced 2.0%	65,666 Common Stock
Sep 02 2025	SELL Open market or private sale	$32,042 $23.93 p/Share	1,339 Reduced 1.96%	67,005 Common Stock
Aug 15 2025	SELL Open market or private sale	$26,833 $20.04 p/Share	1,339 Reduced 1.92%	68,344 Common Stock
Aug 13 2025	SELL Open market or private sale	$838,870 $19.5 p/Share	43,019 Reduced 38.17%	69,683 Common Stock
Aug 08 2025	SELL Payment of exercise price or tax liability	$464,097 $19.36 p/Share	23,972 Reduced 17.54%	112,702 Common Stock
Aug 08 2025	BUY Exercise of conversion of derivative security	-	66,991 Added 32.89%	136,674 Common Stock

DJM

Derek J Maetzold

Pres. & Chief Exec. Officer

Friendswood, TX

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CSTL shares.

Notify only if

Value

Insider Trading

Get notified when an Castle Biosciences Inc insider buys or sells CSTL shares.

Notify only if

Operation

Value

Type

News

Receive news related to CASTLE BIOSCIENCES INC

Track Activities on CSTL

Account